0.87
前日終値:
$0.8715
開ける:
$0.89
24時間の取引高:
1.67M
Relative Volume:
0.91
時価総額:
$88.68M
収益:
$153.73M
当期純損益:
$-106.79M
株価収益率:
-0.4888
EPS:
-1.78
ネットキャッシュフロー:
$-115.93M
1週間 パフォーマンス:
-17.14%
1か月 パフォーマンス:
+44.42%
6か月 パフォーマンス:
-78.68%
1年 パフォーマンス:
-79.04%
Sutro Biopharma Inc Stock (STRO) Company Profile
名前
Sutro Biopharma Inc
セクター
電話
650-392-8412
住所
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
STRO を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
STRO
Sutro Biopharma Inc
|
0.87 | 88.68M | 153.73M | -106.79M | -115.93M | -1.78 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
439.37 | 128.45B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
575.63 | 65.17B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ARGX
Argen X Se Adr
|
560.90 | 40.09B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
270.19 | 35.67B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ONC
Beigene Ltd Adr
|
233.25 | 27.44B | 3.81B | -644.79M | -669.77M | -6.24 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-03-17 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2025-03-14 | ダウングレード | BofA Securities | Buy → Underperform |
2025-03-14 | ダウングレード | Citizens JMP | Mkt Outperform → Mkt Perform |
2025-03-14 | ダウングレード | Wedbush | Outperform → Neutral |
2024-05-08 | 開始されました | BofA Securities | Buy |
2023-11-09 | 開始されました | Deutsche Bank | Buy |
2023-10-06 | 開始されました | Oppenheimer | Outperform |
2023-03-21 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2022-08-18 | 再開されました | Wells Fargo | Overweight |
2021-06-18 | 開始されました | H.C. Wainwright | Buy |
2020-12-03 | 開始されました | Stifel | Buy |
2020-09-02 | 開始されました | Jefferies | Buy |
2020-07-16 | 開始されました | Wells Fargo | Overweight |
2020-01-13 | 開始されました | SunTrust | Buy |
2019-10-07 | 開始されました | BTIG Research | Buy |
2019-07-18 | 開始されました | Deutsche Bank | Buy |
2019-04-29 | 開始されました | H.C. Wainwright | Buy |
2018-10-22 | 開始されました | JMP Securities | Mkt Outperform |
2018-10-22 | 開始されました | Piper Jaffray | Overweight |
2018-10-22 | 開始されました | Wedbush | Outperform |
すべてを表示
Sutro Biopharma Inc (STRO) 最新ニュース
Sutro Biopharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Sold by Barclays PLC - Defense World
Sutro Biopharma Inc Reports Q1 2025 Revenue of $17.4M, Exceeding Estimates; EPS at -$0.91, Missing Projections - GuruFocus
Sutro Biopharma First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Sutro Biopharma earnings missed by $0.06, revenue topped estimates - Investing.com Canada
Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Tops Revenue Estimates - NewsBreak: Local News & Alerts
Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights - The Manila Times
Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights | STRO Stock News - GuruFocus
Sutro Biopharma, Inc. Advances ADC Pipeline Focus with Promising Preclinical Results and Strategic Reprioritization - Nasdaq
Financial Metrics Check: Sutro Biopharma Inc (STRO)’s Ratios for Trailing Twelve Months - DWinneX
Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Bought by Invesco Ltd. - Defense World
Sutro Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail
Sutro Biopharma to Participate in Upcoming Investor Conferences - The Manila Times
Leading ADC Developer Sutro Biopharma to Present at Citizens and BofA Healthcare Conferences in May - Stock Titan
New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty - Benzinga
Sutro Biopharma (NASDAQ:STRO) Earns “Neutral” Rating from HC Wainwright - Defense World
Taking the lead: Sutro Biopharma Inc (STRO) - Sete News
Brokerages Set Sutro Biopharma, Inc. (NASDAQ:STRO) Price Target at $6.63 - The AM Reporter
Sutro Biopharma Inc [STRO] Investment Appeal on the Rise - knoxdaily.com
Demystifying Sutro Biopharma: Insights From 4 Analyst Reviews - Nasdaq
A stock that deserves closer examination: Sutro Biopharma Inc (STRO) - uspostnews.com
Sutro Biopharma to Highlight its Next-Generation Exatecan and Du - GuruFocus
Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025 - The Manila Times
Sutro Biopharma Announces Poster Presentations on STRO-004 and XpressCF+® Platform at 2025 AACR Annual Meeting - Nasdaq
Revolutionary Dual-Payload Cancer Drug Shows Promise: Sutro's Next-Gen ADC Technology Impresses at AACR 2025 - Stock Titan
Sutro Biopharma Inc (STRO) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Recommendation of “Hold” from Analysts - Defense World
Russell Investments Group Ltd. Has $183,000 Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
New fund will pressure flailing biotechs, as investor frustration boils over - Endpoints News
LPL Financial LLC Has $667,000 Stock Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Sutro Biopharma Inc (STRO) gets rating Downgrade from H.C. Wainwright - knoxdaily.com
Anchoring Your Portfolio: Is STRO Stock a Safe Harbor? - investchronicle.com
Take off with Sutro Biopharma Inc (STRO): Get ready for trading - Sete News
Sutro Biopharma Inc (NASDAQ: STRO) – Analysts’ Revisions Point To Positive Sentiment - Stocksregister
Layoff Tracker: Tempest Axes 80% of Workforce - BioSpace
Benign Growth For Sutro Biopharma, Inc. (NASDAQ:STRO) Underpins Stock's 36% Plummet - simplywall.st
Sutro Biopharma stock hits 52-week low at $0.54 amid market challenges By Investing.com - Investing.com South Africa
Sutro Biopharma stock hits 52-week low at $0.54 amid market challenges - Investing.com Canada
Sutro Biopharma, Inc. (NASDAQ:STRO) Stock Holdings Boosted by American Century Companies Inc. - Defense World
Sutro Biopharma announces board member departure By Investing.com - Investing.com Canada
Sutro Biopharma announces board member departure - Investing.com Australia
Sei Investments Co. Takes Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Changing FacesPharma and Biotech HiresMarch 2025 - pharmaphorum
Prudential Financial Inc. Increases Stock Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Thrivent Financial for Lutherans Acquires Shares of 97,096 Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Sutro Biopharma stock hits 52-week low at $0.58 amid market challenges By Investing.com - Investing.com South Africa
Sutro Biopharma stock hits 52-week low at $0.58 amid market challenges - Investing.com
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Rating of “Hold” from Analysts - Defense World
Sutro Biopharma Inc (STRO) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):